ER |
Endoplasmic reticulum |
GALNT |
N-acetylgalactosaminyltransferase |
GalNAc |
N-acetylgalactosamine |
FUT8 |
α-(1,6)-fucosyltransferase |
GLCNAc-TV or MGAT5 |
N-acetylglucosaminyltransferase |
GDP-β-l-fucose |
Guanosine diphosphate |
GMD |
GDP-mannose 4,6-dehydrastase |
FX protein |
GDP-keto-6-deoxymannose 3,5-epimerase, 4-reductase |
NADPH |
Nicotinamide adenine dinucleotide phosphate |
AFP |
α-fetoprotein |
HCC |
Hepatocellular carcinoma |
LCA |
Lens culinaris agglutinin |
PCa |
Prostate Cancer |
PSA |
Prostate Specific Antigen |
BPH |
Benign Prostate Hyperplasia |
HPLC |
High-performance liquid chromatography |
AAL |
Aleuria aurantica lectin |
AGP |
α1-acid glycoprotein |
CAIE |
Crossed affinoimmunoelectrophoresis |
fAGP |
α1,3fucosylated AGP |
RPN1 |
Ribophorin I |
FUTs |
Fucosyltransferases |
NSCLC |
Nonsmall cell lung cancer |
LEF-1 |
Lymphoid enhancer binding factor 1 |
CRC |
Colorectal cancer |
DFS |
Disease free survival |
EOC |
Epithelial Ovarian Cancer |
cDDP |
Cisplatin |
CTR1 |
Copper transporter 1 |
PrECs |
Prostate epithelial cells |
PrSCs |
Prostate stromal cells |
ADT |
Androgen Deprivation Therapy |
EV |
Extracellular Vesicles |
PDAC |
Pancreatic ductal adenocarcinoma |
ADCC |
Antibody-dependent cellular cytotoxicity |
PD-1 |
Programmed cell death |
TGF-β |
Transforming growth factor- β1 |
EGF |
Epidermal growth factor |
FcRs |
Lymphocyte receptors |
Fc |
Constant region |
IgG |
Immunoglobulin G |
CHO |
Chinese hamster ovary |
EMT |
Epithelial-mesenchymal transition |
E-box |
Enhancer box |
ZFNs |
Zinc-finger nucleases |
SGN-2FF |
2-fluorofucose |
FDA |
US Food and Drug Administration |
NHL |
Non-Hodgkin’s lymphoma |
CTCL |
T-cell lymphoma |
HTLV1 |
T-lymphotrophic virus 1 |